ATP11AUN
Putative protein ATP11AUN
Also known as: ATPUN_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for ATP11AUN in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
121 residues, UniProt reviewed canonical sequence.
>Q6ZP68|ATP11AUN
1 MNSPEARLCV AQCRDSYPGC QPLKDTRAWA SSLKMDPAGL EGGPRDESRD EPPIRAQAAS
61 WDQPQGCLTY KGRRSASGTQ KQLQLPDTLS SLLCWRGAIM VYIKVTVQTD DSNKLLSLLY
121 RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP11AUN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP11AUN as an antibody target. Whether an autoantibody or antibody against ATP11AUN could matter depends on whether native ATP11AUN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP11AUN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP11AUN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...